Parion Sciences is a Durham, North Carolina-based biotechnology company focused on restoring mucosal surface defenses in the lung and eye.

We develop science-driven technologies targeting respiratory and ocular diseases, often stemming from compromised innate host defenses. Our pipeline, including ENAC, PULMONARY, and tPAD programs, addresses critical unmet needs in these areas.

Parion Sciences leverages a deep understanding of mucosal immunology and innovative formulation technologies to create novel therapies. We are dedicated to improving patient outcomes through targeted treatments for diseases like Primary Ciliary Dyskinesia and other respiratory conditions.

Founded in 2000, Parion Sciences has a strong track record of research and development, with a team of experienced scientists and a commitment to advancing patient care.

ENAC | Parion Sciences

Product description

Parion Sciences Durham, United States (US)

Price: N/A

Parion Sciences
Durham, United States (US)